The mechanism by which it promotes AD progression may be the upregulation of miR-34c, which exacerbates synaptic defects and affects cognitive function by mediating the ROS-JNK-p53 pathway targeting the prominent protein binding site 1 (SYT1) [178]. The gene discussed is SYT1; the disease is Alzheimer disease.